远大医药(00512)：全球创新的治疗蠕形螨睑缘炎产品上市许可申请获中国药监局受理SSY GROUP (02005): Fumaric acid voronol and hydrochloride dronederone have been approved for registration by the National Medical Products Administration to be used as Active Pharmaceutical Ingredient in market preparations; GRANDPHARMA (00512): The application for market approval of the globally innovative treatment for Demodex blepharitis has been accepted by the China National Medical Products Administration.
[Significant Events]
SSY GROUP (02005): Fumaric acid voronol and hydrochloride dronederone have been approved for registration by the National Medical Products Administration to be used as Active Pharmaceutical Ingredient in market preparations.
GRANDPHARMA (00512): The application for marketing authorization of the globally innovative treatment product for demodex blepharitis has been accepted by the China National Medical Products Administration.
Heyu-B (02256): CDE has approved the initiation of a registrational clinical study of Ipagotene (ABSK011) for patients with HCC.
Huaxin Cement (06655) plans to spend approximately 0.1866 billion dollars to acquire four aggregate plants in Brazil.
HANSOH PHARMA (03692): The B7-H3 targeted antibody drug conjugate HS-20093 has received EMA priority medicine designation.
CANSINOBIO (06185): The new drug for infants and young children, DTcP, has had its market application accepted.
DALIPAL HLDG (01921) subsidiary has been approved to be included in the Saudi Aramco electronic market supplier database.
Microneuroscience (02172) plans to invest 0.2 billion yuan to establish an investment fund to support the development of brain science and brain-like intelligence Industry.
[Earnings Reports Data]
CHINA SOUTH AIR (01055) saw a year-on-year increase of 7.18% in passenger capacity投入 in November.
CTIHK (06055) issued a profit alert, expecting its annual profit attributable to Shareholders to increase by no less than 30% year-on-year.
CHINA EAST AIR (00670) saw an increase of 9.19% year-on-year in passenger transport capacity investment in November.
TOPSPORTS (06110) reported a year-on-year decline in the total sales amount of its retail and wholesale Business in the third quarter.
YIDA CHINA (03639) reported the contract sales amount for the first 11 months to be approximately 0.887 billion yuan, a decrease of 28.98% year-on-year.
CHINA RES POWER (00836) reported that the cumulative electricity sales of its subsidiary power plants reached 0.188 billion megawatt-hours for the first 11 months, an increase of 8.2% year-on-year.
For more details, please refer to 智通财经网().
